Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

How Has the Inherited Retinal Disease Market Growth Performance Trended Historically, And What Lies Ahead?

The market size for inherited retinal diseases has seen significant growth over the past few years. The market is expected to expand from $11.56 billion in 2024 to $12.58 billion in 2025, with a compound annual growth rate (CAGR) of 8.8%. This substantial growth during the historical period is largely due to factors such as the implementation of gene therapy, regulatory incentives, expansion of patient registries, an increase in clinical trials, and the growth of solutions focused on patients.

The market size for inherited retinal disease is forecasted to experience robust growth in the coming years, expanding to $17.42 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 8.5%. The upswing during this projection period is due to factors such as the widespread adoption of CRISPR technology, the advent of personalized medicine, emphasis on regenerative healthcare, increased patient advocacy, and the drive to enhance patients’ quality of life. Noteworthy trends predicted for this period include the progress in optogenetics technology, the emergence of artificial retina implants, the growth of digital health platforms, the integration of artificial intelligence in disease modeling, and the application of artificial intelligence in treatment planning.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20850&type=smp

What External and Internal Drivers Are Contributing to the Growth of the Inherited Retinal Disease Market?

The escalating incidences of macular degeneration are forecasted to boost the inherited retinal disease market’s expansion going forward. Macular degeneration is an eye condition related to aging that inflicts damage on the macula, causing loss of central vision and making tasks such as reading or distinguishing faces challenging. The surging incidences of macular degeneration are spurred by older populations, increased life expectancy, and lifestyle elements like smoking and poor nutrition that intensify the risk. Treatment of inherited retinal diseases aids individuals suffering from macular degeneration by focusing on the genetic factors leading to retinal degeneration, offering therapies that retard the disease’s progression, reestablish lost sight, or even halt further retinal harm, ultimately enhancing visual outcomes and the quality of life of individuals suffering from age-related or inherited types of macular degeneration. In February 2024, for example, the Canadian Ophthalmological Society, a nonprofit organization based in Canada, revealed that 2.5 million Canadians aged 55 and over lost their vision due to age-related macular degeneration (AMD). Consequently, the escalating incidences of macular degeneration are propelling the inherited retinal disease market’s growth.

What Segment Types Define the Inherited Retinal Disease Market Structure?

The inherited retinal disease market covered in this report is segmented –

1) By Type: Diagnosis, Therapy

2) By Disease Type: Retinitis Pigmentosa, Choroideremia, Stargardt Disease, Cone-rode Dystrophy, Leber Congenital Amaurosis, Other Diseases

3) By Distribution Channel: Retail Sales, Direct Tender

4) By End Users: Hospitals, Speciality Clinics, Ambulatory Surgical Centres, Home Healthcare, Other End Users

Subsegments,

1) By Diagnosis: Genetic Testing (Genetic Screening), Retinal Imaging (Fundus Photography, Optical Coherence Tomography (OCT)), Electrophysiological Testing (Electroretinography), Visual Field Testing, Fundus Autofluorescence Imaging

2) By Therapy: Gene Therapy, Stem Cell Therapy, Retinal Prosthesis (Artificial Retina), Pharmacological Therapy (Gene Editing, Retinal Drugs), Photoreceptor Rescue Therapy

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=20850&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Inherited Retinal Disease Market?

North America was the largest region in the inherited retinal disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inherited retinal disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Current Market Growth and Trends in the Inherited Retinal Disease Industry?

Leading corporations in the inherited retinal diseases market are concentrating on the development of novel treatments like mutation-agnostic gene therapy, which can offer comprehensive treatment alternatives and cater to a broader variety of genetic variances linked with such diseases. This form of therapy targets overall genetic processes or pathways, instead of individual mutations, making it suitable for a wide array of genetic disorders. For example, Nanoscope Therapeutics Inc, a biotechnology company based in the US, shared positive outcomes of a clinical trial for its main program, MCO-010, in March 2024. This program presented significant vision enhancement in patients suffering from advanced retinitis pigmentosa, which cause severe and permanent vision loss. The primary and key secondary endpoints of MCO-010 were successfully met, with no serious side effects reported.

View the full report here:

https://www.thebusinessresearchcompany.com/report/inherited-retinal-disease-global-market-report

What Is the Definition of the Inherited Retinal Disease Market?

Inherited retinal diseases are a group of rare, genetic eye disorders caused by mutations in specific genes. These diseases primarily affect the retina, the thin layer of light-sensitive tissue at the back of the eye. They often present challenges for treatment due to their genetic complexity, but advancements in gene therapy and other innovative technologies offer promising solutions.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20850

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model